While many in the marijuana stock market are focused on investing in the companies that grow the physical plant, there is a large amount of opportunity in newfound companies that invest in the cannabis industry as a whole. These companies strategically look for high cash flow businesses with a large amount of potential for the future of the industry.

The industry on investing in cannabis is very much a new one, which means that the boundaries for putting money in are not yet fully established. Despite this, many of these companies have combined years of experience, and therefore have a better idea of which companies could potentially see success in the coming years.

A new marijuana production facility attracted investors to a Canadian cannabis stock Wednesday.

Here’s some small stocks making big moves on Wednesday, February 20, 2019 (as of 11:30 am EST):

Emerald Health Therapeutics, Inc. (TSXV:EMH), a Canadian cannabis stock, jumped 10% to $3.71 on Wednesday after announcing the launch of Verdélite Sciences Inc., a wholly-owned, Québec-based production subsidiary licensed by Health Canada, which currently produces high-grade dried cannabis for medical and adult-use purposes.

Cannabis producer Tilray Inc. has signed a deal to acquire Hemp Hearts-maker Manitoba Harvest for up to $419 million in cash and stock as the two companies look to launch CBD-infused products where permissible in the U.S.

The acquisition accelerates the Nanaimo, B.C.-based pot grower's entry into the U.S. market as the hemp food manufacturer's products are already on the shelves of retailers such as Wal-Mart, Costco and Whole Foods on both sides of the border, said Tilray chief executive Brendan Kennedy.

Tilray will look to leverage the food maker's manufacturing facilities in Manitoba and its supply chain to roughly 16,000 stores where their products are already sold in North America, he added.

The Canadian marijuana stocks we have weeded out today have accumulated large short positions following the early 2019 rally, fueled by the signing of the U.S. Farm Bill into law in late December.

Additional developments that have helped sustain the sector-wide rally include Israel and Columbia, which both announced that the countries would allow cannabis exports, and Florida announcing it would repeal the ban on smokable flower in its medical cannabis program. This rally, however, has been accompanied by a spike in short interest.

The clock is ticking down, a hand hovers over the bell, a trainer is shouting “hang on! Just a few more seconds!” from the corner of the ring. Canada is in the throws of the first round of cannabis legalization.

The match started in October of last year—the veteran black market in one corner, the rookie hotshot Health Canada in the other. Both came out swinging, and both have landed some stellar blows. The entire arena is awash with the hollering and jeering of fervent fans: companies, consultants, consumers, and media, all will heavy bets invested in one of them lying facedown, dejected and bloodied, by the end of the match.

As recreational cannabis use becomes more and more accepted following legalization, a large number of distributors are slowly making their way into more markets. The latest cannabis distributor to make their way into the Alberta market is one of the largest in the nation. This newest supplier Zenabis is one of the largest in Canada and will be offering new premium strains to Alberta. As always, we have the inside scoop for you and all your recreational needs. 

The gift bags given to celebrities at the Oscars often contain six figures worth of lavish products, but it’s not the luxury small ship adventure that’s stealing the spotlight this year – it’s cannabis.

A broad collection of cannabis products will be featured for the first time in the swag bags. Lash Fary, founder of Distinctive Assets, the brand that puts together and distributes the gift bags, told Forbes that the inclusion of cannabis products is tied to the legalization of marijuana in California. Fary says the products are designed to help celebrities with their stress and anxiety.

Following an ugly fourth quarter, marijuana stocks are on fire once again. In January, the Horizons Marijuana Life Sciences ETF, the first-ever cannabis ETF to trade in Canada, gained close to 50%, with 15 out of roughly four dozen pot stocks rising by at least 50%.

Why such optimism, you ask? Look no further than the legalization of recreational weed in Canada last October, which ended nine decades of adult-use prohibition, and the ongoing legalization of pot at the state level in the United States. Going green in Canada is expected to balloon sales in the country from a few hundred million dollars to perhaps as much as $6 billion by 2022.

Cannabis managed to bring in $17.4 million in sales for the Nova Scotia Liquor Corporation in the first few months of legalization, but that wasn't enough to make the bud profitable for the provincial Crown corporation. 

"We're not making money on cannabis at this point because of the implementation costs," NSLC spokesperson Beverly Ware said Tuesday. 

Those costs include renovating stores, purchasing products, along with the hiring and training of new employees. 

Contrary to popular perception, British Columbians are not the heaviest users of recreational marijuana, according to new figures from Statistics Canada.

That high-standing belongs to residents of Nova Scotia, where almost 22 per cent of the population (21.6 per cent) aged 15 years and up reported using cannabis during the last three months of 2018. That share amounts to about 170,400 people of the provincial population.